Aclaris Therapeutics
ACRS
#7835
Rank
โ‚น29.39 B
Marketcap
โ‚น271.31
Share price
3.79%
Change (1 day)
27.53%
Change (1 year)

Earnings for Aclaris Therapeutics (ACRS)

Earnings in 2025 (TTM): -โ‚น12.2 Billion

According to Aclaris Therapeutics's latest financial reports the company's current earnings are โ‚น15.74 Million. In 2024 the company made an earning of -โ‚น11.91 Billion a decrease over its 2023 earnings that were of -โ‚น8.01 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aclaris Therapeutics from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น12.2 Billion2.43%
2024 -โ‚น11.91 Billion48.64%
2023 -โ‚น8.01 Billion2.23%
2022 -โ‚น7.84 Billion-4.35%
2021 -โ‚น8.2 Billion77%
2020 -โ‚น4.63 Billion-54.79%
2019 -โ‚น10.24 Billion-5.87%
2018 -โ‚น10.88 Billion71.46%
2017 -โ‚น6.35 Billion46.33%
2016 -โ‚น4.34 Billion133.81%
2015 -โ‚น1.86 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น13.35 Billion 4.48%๐Ÿ‡บ๐Ÿ‡ธ USA